
On February 4, leading brokerages highlighted their top stock picks, offering strong upside potential for investors. Here’s a summary of the positively rated stocks along with their current market prices (CMP) and projected upside based on target prices.
Top brokerage recommendations for stocks to buy today:
Citi on LIC Housing: Citi raised its target price on LIC Housing to ₹851 per share while maintaining a Buy rating. With the stock currently trading at ₹557.95, this reflects a potential upside of 52.6% from the current market price.
Jefferies on ONGC: Jefferies maintained a Buy rating on ONGC with a target price of ₹375 per share. The stock is currently priced at ₹251.10, offering an upside potential of 49.3% from its CMP.
Motilal Oswal (MOSL) on Vinati Organics: MOSL maintained a Buy rating on Vinati Organics with a target price of ₹2,600 per share. Given its CMP of ₹1,749.00, the stock has a potential upside of 48.7%.
Goldman Sachs on Adani Ports: Goldman Sachs maintained a Buy rating on Adani Ports, setting a target price of ₹1,560 per share. With a CMP of ₹1,086.90, the stock offers apotential upside of 43.5% from current levels.
Bernstein on PayTM: Bernstein maintained an Outperform rating on PayTM, with a target price of ₹1,100 per share. The stock, currently trading at ₹771.00, shows a potential upside of 42.6%.
Nomura on LIC Housing: Nomura maintained a Buy rating, raising its target price to ₹735 per share. This indicates a potential upside of 31.7% from the current market price of ₹557.95.
HSBC on Aster DM: HSBC maintained a Buy rating on Aster DM with a target price of ₹580 per share. The stock’s CMP of ₹469.00 suggests an upside potential of 23.7%.
Citi on Divis Lab: Citi maintained a Buy rating on Divis Lab with a target price of ₹6,850 per share. With its current price at ₹5,949.90, the stock offers a potential upside of 15.1%.
Nuvama on Divis Lab: Nuvama echoed a similar sentiment, maintaining a Buy rating with a target price of ₹6,830 per share, implying an upside of 14.8% from its CMP.
Morgan Stanley on Maruti: Morgan Stanley remains optimistic about Maruti, maintaining an Overweight rating with a target price of ₹14,942 per share. Trading at ₹13,120.00, this suggests an upside potential of 13.9%.
Disclaimer: The views and investment tips expressed by brokerages are their own and not those of Business Upturn. Investors are advised to consult certified financial experts before making any investment decisions.